1 Respect of legal and ethical rights
Novo Nordisk recognises its responsibility to respect the legal
and ethical rights of the people who donate human biosamples.
2 Compliance of laws and regulations
Novo Nordisk’s research using human biosamples complies with
all relevant national and international laws and regulations and takes
note of external guidelines on bioethics and best practice, insofar as
they apply. Novo Nordisk’s internal governance processes assure the
legality and ethics of its uses of biosamples.
3 Consent of donation
Biosamples must be donated with appropriate consent, or with
legally and societally acceptable alternatives to individual donor
consent where necessary. Consent to donate human biosamples should not
be influenced by coercion, financial inducements or give rise to
financial gain for the donor or next of kin. All uses of biosamples
and data must always be within the scope of consent.
4 Right to withdraw consent
The right of donors to withdraw consent for future uses of
their biosamples must be respected, where practicable, without
question and without detriment to their clinical care.
5 Financial transactions
Novo Nordisk has strict standards for financial transactions
relating to the acquisition of human biosamples for research uses.
These are aligned with Article 21 of the Convention on Human Rights
and Biomedicine of the Council of Europe, which states that the human
body and its parts must not directly give rise to financial gain.
6 Approval by ethics committee
Public trust and confidence are protected by ensuring that
research activities using human biosamples and data are approved by an
ethics committee (EC) / Institutional Review Board (IRB) or
equivalent, where applicable.
7 Privacy protection
Novo Nordisk protects the privacy of people who donate human
biosamples by safeguarding the use of biosamples and sensitive
personal data with appropriate security measures.
8 Clinical trials
Novo Nordisk’s position on Clinical trials covers additional
aspects of the use of human biosamples and data obtained from people
enrolled in our clinical trials.
9 Stem cells
Novo Nordisk’s position on Stem cells covers additional aspects
of the use of stem cells in research and the development of cellular therapeutics.